Delivery Order SPE2DE24D0013-SPE2D626F0542
- Not listed
- The Defense Logistics Agency awarded a $40.8K delivery order (Contract 4569470191) to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, for the supply of COVID-19/Flu/RSV testing solutions. This firm fixed-price delivery order, with an ultimate completion date of September 23, 2025, carries no set-aside designation and represents part of Cepheid's broader supply relationship with the Defense Department's medical supply chain operations. Cepheid specializes in...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded Cepheid Inc. a delivery order valued at $22,240 on September 9, 2025, for molecular diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV). This firm fixed-price delivery order, which has no set-aside designation, is scheduled for completion by September 16, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. Cepheid is a for-profit...
- The Defense Logistics Agency's Medical Supply Chain branch awarded a $34,000 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostic manufacturer based in Sunnyvale, California, for 10 tests of a COVID-19/Influenza/RSV diagnostic kit. The contract, issued on May 29, 2025, is scheduled for completion by June 6, 2025, with performance taking place in Sunnyvale. This delivery order carries no set-aside designation and represents a continuation of Cepheid's ongoing support to federal...
- The U.S. Defense Logistics Agency, acting under the Medical Supply Chain portfolio, awarded a $9,520 firm fixed-price delivery order to Cepheid Inc. on September 12, 2025, with completion targeted for September 19, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, supports molecular diagnostic testing capabilities and is being performed at Cepheid's facility in Sunnyvale, California. This award carries no set-aside designation and represents a continuation of the federal government's...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $9,520 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on August 6, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by August 13, 2025, and carries no set-aside designation. The contract nomenclature indicates the order pertains to diagnostic testing capabilities for COVID-19, influenza, and respiratory...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $7,480 firm fixed-price delivery order to Cepheid Inc. on September 16, 2025, with an ultimate completion date of September 30, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The award carries no set-aside designation and represents a continuation of Cepheid's longstanding role as a primary...
- The Defense Logistics Agency awarded a $12,240 firm fixed-price delivery order to Cepheid Inc. for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract, with an ultimate completion date of August 15, 2025, was awarded on August 8, 2025, with no set-aside designation. Cepheid, a Sunnyvale, California-based manufacturer specializing in molecular diagnostic systems and test kits, will perform the work at its California...
- This delivery order, awarded on July 24, 2025, represents a $17,680 firm fixed-price contract between the Defense Logistics Agency's Medical Supply Chain division and Cepheid Inc. for a COVID-19/Influenza/RSV diagnostic kit containing 10 viral tests. The contract is set to be completed by July 31, 2025, with performance taking place at Cepheid's headquarters in Sunnyvale, California. This award is issued without a set-aside designation and falls under Cepheid's existing indefinite delivery...
- The Defense Logistics Agency (Defense organization under the Medical Supply Chain) awarded a $16.3K firm fixed-price delivery order to Cepheid Inc. for a COVID-19/Influenza/RSV diagnostic test kit (10-test viral test kit) on July 23, 2025, with an ultimate completion date of July 30, 2025. The order will be fulfilled at Cepheid's facility in Sunnyvale, California. This delivery order carries no set-aside designation and represents a routine procurement of molecular diagnostic testing solutions...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $13,980 to Cepheid Inc. for COVID-19/Influenza/RSV diagnostic test kits on August 8, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents procurement of molecular diagnostic testing solutions from the Sunnyvale, California-based manufacturer. The delivery order will be performed at Cepheid's Sunnyvale facility. This...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F0542Delivery Order
The Defense Logistics Agency, through its Medical Supply Chain division, awarded a delivery order valued at $9,520 to Cepheid Inc. for the supply of COVID-19/Flu/RSV diagnostic test kits (10 tests per kit). This firm fixed-price delivery order, issued on October 6, 2025, with an ultimate completion date of October 14, 2025, carries no set-aside designation. The work will be performed at Cepheid's facility in Sunnyvale, California. This delivery order likely draws from one of Cepheid's existing indefinite delivery vehicles with the Department of Veterans Affairs, which provide the company with a framework for supplying molecular diagnostic testing solutions across federal healthcare systems. Cepheid is a established manufacturer of molecular diagnostic systems and test kits specializing in infectious disease detection. The company has demonstrated substantial capacity to support federal healthcare agencies through multiple prime contracts with the Veterans Health Administration and Defense Health Agency, with existing IDV contracts valued at over $35 million supporting ongoing procurement of diagnostic reagents and assays through 2030. This contract award reflects Cepheid's continued role as a primary supplier of rapid diagnostic testing capabilities for respiratory pathogens to federal medical supply chains, supporting the government's ongoing public health readiness and clinical laboratory operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.5k | 10/6/25 |